Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Primary Myelofibrosis 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Acute 2Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Leukemia, Neutrophilic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Lacrimal Apparatus Diseases 1Lacerations 1

Interventions

Isotretinoin 3imetelstat 2Peripheral Blood Stem Cell Transplantation 2Cyclophosphamide 2thymoglobulin 1pazopanib 1naxitamab 1lorukafusp alfa 1liposomal doxorubicin 1keyhole-limpet hemocyanin 1fludarabine phosphate 1fludarabine 1defibrotide 1arginyllysine 1Whole-Body Irradiation 1Whole Body Imaging 1Vincristine 1Vaccines 1Tretinoin 1Topotecan 1Thiotepa 1Therapeutics 1Temozolomide 1Tacrolimus 1Stem Cell Transplantation 1Spermine Synthase 1Specimen Handling 1Radiotherapy 1Radiation 1Pentetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neuroblastoma × Cyclosporins × Clear all
NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Nationwide Children's Hospital

Phase 2 Withdrawn
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡